University Hospital Southampton NHS Foundation Trust Revenue and Competitors

Southampton, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • University Hospital Southampton NHS Foundation Trust's estimated annual revenue is currently $1.9B per year.(i)
  • University Hospital Southampton NHS Foundation Trust's estimated revenue per employee is $378,000

Employee Data

  • University Hospital Southampton NHS Foundation Trust has 4921 Employees.(i)
  • University Hospital Southampton NHS Foundation Trust grew their employee count by 6% last year.

University Hospital Southampton NHS Foundation Trust's People

NameTitleEmail/Phone
1
Chief Cardiac PhysiologistReveal Email/Phone
2
CEOReveal Email/Phone
3
Head Information GovernanceReveal Email/Phone
4
Project OfficerReveal Email/Phone
5
Press officerReveal Email/Phone
6
Head DepartmentReveal Email/Phone
7
Failsafe OfficerReveal Email/Phone
8
Head Imaging in ResearchReveal Email/Phone
9
Discharge OfficerReveal Email/Phone
10
Head Nursing for Education, Practice and StaffingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M520%N/AN/A
#2
$37M1375%N/AN/A
#3
$16.5M68-16%N/AN/A
#4
$42.5M1434%N/AN/A
#5
$48.4M1636%N/AN/A
#6
$25.1M930%N/AN/A
#7
$8.6M4011%N/AN/A
#8
$234.2M6945%N/AN/A
#9
$85.5M28810%N/AN/A
#10
$24.8M927%N/AN/A
Add Company

What Is University Hospital Southampton NHS Foundation Trust?

University Hospital Southampton NHS Foundation Trust (UHS) is one of the UK’s most innovative healthcare providers and a pioneer in medical research. Rated 'Good' by the CQC in 2017, we cover a broad spectrum of services, including specialist services such as neurological, cardiac and children’s intensive care.\n\nPutting patients first is at the heart of everything we do. We work collaboratively to explore new and improved ways of delivering patient-centered care. By empowering our people to innovate, we push the boundaries of medicine to positively impact on patients’ lives.\n\nWe are committed to innovation and research, encouraging all staff at UHS to share their ideas, and working in partnership with a wide variety of research institutions. We harness the power of teams and pioneer new healthcare methods to consistently deliver high quality patient outcomes. For example:\n\n• We were the first hospital in England to use stem cell injections to improve mobility after stroke\n\n• We introduced bedside bikes on the recommendation of our Physiotherapy team, reducing patient recovery times\n\n• We were one of the first Genomic Medicine Centres in the UK to specialise in diagnosis and treatment of patients with rare diseases and cancers\n\nWe take pride in enhancing the skills of our staff to aid their career development - facilitated by high quality training and opportunities in a variety of areas - supporting them to reach their full potential.\n\n• We provide hospital services to around 1.9 million people in Southampton and south Hampshire\n\n• Every year, we treat over 140,000 inpatients and day patients\n\n• We also see over 500,000 outpatients and treat over 100,000 emergency cases

keywords:N/A

N/A

Total Funding

4921

Number of Employees

$1.9B

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

University Hospital Southampton NHS Foundation Trust News

2022-04-20 - The COV-Boost study, led by Prof Saul Faust and researchers ...

COV-BOOST is being led by University Hospital Southampton NHS Foundation Trust and delivered by a network of trial sites across the UK.

2022-04-13 - Medical Retina Consultant (Ophthalmologist) job with ...

Medical Retina Consultant (Ophthalmologist). Go to University Hospital Southampton NHS Foundation Trust profile. Recruiter: University Hospital...

2022-04-06 - University Hospital Southampton suspends visiting amid norovirus outbreak and number of Covid-19 cases

In a statement on Facebook, University Hospital Southampton NHS Foundation Trust said: "This is not a decision we would want to take,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1836.5M51857%N/A